BioNano Genomics, Inc. (BNGO) Reports Q4 Net Loss of $29.5M
Tweet
Share
E-mailGet Alerts BNGO Hot Sheet
Join SI Premium – FREE
BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q4 net loss of $29.5M. Revenue for the quarter came in at $6.3 million versus the consensus estimate of $5.57 million.
GUIDANCE:
BioNano Genomics, Inc. sees FY2022 revenue of $24-27 million.
For earnings history and earnings-related data on BioNano Genomics, Inc. (BNGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
